These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36204527)
21. Illicit Internet availability of drugs subject to recall and patient safety consequences. Mackey TK; Aung P; Liang BA Int J Clin Pharm; 2015 Dec; 37(6):1076-85. PubMed ID: 26148859 [TBL] [Abstract][Full Text] [Related]
22. Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries. Rasheed H; Höllein L; Holzgrabe U Front Pharmacol; 2018; 9():995. PubMed ID: 30233373 [TBL] [Abstract][Full Text] [Related]
23. Substandard and counterfeit medicines: a systematic review of the literature. Almuzaini T; Choonara I; Sammons H BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188 [TBL] [Abstract][Full Text] [Related]
24. A nationwide web-based survey of a sample of Italian community pharmacists' perceptions and opinions about online sales of medicines and falsified drugs. Lombardo S; Marino F; Cosentino M Pharm Pract (Granada); 2019; 17(4):1593. PubMed ID: 31897254 [TBL] [Abstract][Full Text] [Related]
25. Evaluating aspects of online medication safety in long-term follow-up of 136 Internet pharmacies: illegal rogue online pharmacies flourish and are long-lived. Fittler A; Bősze G; Botz L J Med Internet Res; 2013 Sep; 15(9):e199. PubMed ID: 24021777 [TBL] [Abstract][Full Text] [Related]
26. Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review. Sorato MM; Davari M; Kebriaeezadeh A J Med Access; 2024; 8():27550834241236598. PubMed ID: 38476401 [TBL] [Abstract][Full Text] [Related]
27. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo. Schäfermann S; Hauk C; Wemakor E; Neci R; Mutombo G; Ngah Ndze E; Cletus T; Nyaah F; Pattinora M; Wistuba D; Helmle I; Häfele-Abah C; Gross H; Heide L Am J Trop Med Hyg; 2020 Aug; 103(2):894-908. PubMed ID: 32394884 [TBL] [Abstract][Full Text] [Related]
28. [Health alerts for substandard, falsified, and unregistered medical products at the onset of the COVID-19 pandemic in the AmericasAlertas de saúde para produtos médicos abaixo do padrão, falsificados e não registrados no início da pandemia de COVID-19 nas Américas]. Gorordo M; Rojas-Cortés R; Carino J; Vahos Zambrano J; Castro JL Rev Panam Salud Publica; 2024; 48():e7. PubMed ID: 38370134 [TBL] [Abstract][Full Text] [Related]
29. Legal aspects of counteracting the trafficking of falsified medicines in the european union. Pashkov V; Soloviov A; Olefir A Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815 [TBL] [Abstract][Full Text] [Related]
30. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance. Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563 [TBL] [Abstract][Full Text] [Related]
31. Value for money of medicine sampling and quality testing: evidence from Indonesia. Valente de Almeida S; Hauck K; Njenga S; Nugrahani Y; Rahmawati A; Mawaddati R; Saputra S; Hasnida A; Pisani E; Anggriani Y; Gheorghe A BMJ Glob Health; 2024 Sep; 9(9):. PubMed ID: 39313254 [TBL] [Abstract][Full Text] [Related]
32. Multifactor Quality and Safety Analysis of Antimicrobial Drugs Sold by Online Pharmacies That Do Not Require a Prescription: Multiphase Observational, Content Analysis, and Product Evaluation Study. Mackey TK; Jarmusch AK; Xu Q; Sun K; Lu A; Aguirre S; Lim J; Bhakta S; Dorrestein PC JMIR Public Health Surveill; 2022 Dec; 8(12):e41834. PubMed ID: 36563038 [TBL] [Abstract][Full Text] [Related]
33. Global scenario of counterfeit antimalarials: A potential threat. Arora T; Sharma S J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727 [TBL] [Abstract][Full Text] [Related]
34. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country. Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489 [TBL] [Abstract][Full Text] [Related]
35. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Mackey TK; Nayyar G Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea. Kaur H; Allan EL; Mamadu I; Hall Z; Green MD; Swamidos I; Dwivedi P; Culzoni MJ; Fernandez FM; Garcia G; Hergott D; Monti F BMJ Glob Health; 2017; 2(4):e000409. PubMed ID: 29082025 [TBL] [Abstract][Full Text] [Related]
37. Current challenges in the detection and analysis of falsified medicines. Bakker-'t Hart IME; Ohana D; Venhuis BJ J Pharm Biomed Anal; 2021 Apr; 197():113948. PubMed ID: 33582458 [TBL] [Abstract][Full Text] [Related]
38. Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal. Fittler A; Ambrus T; Serefko A; Smejkalová L; Kijewska A; Szopa A; Káplár M Front Pharmacol; 2022; 13():1070473. PubMed ID: 36642991 [TBL] [Abstract][Full Text] [Related]
39. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement. Mackey TK; Cuomo RE Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014 [No Abstract] [Full Text] [Related]
40. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries. Hauk C; Hagen N; Heide L Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]